The Fellowships are awarded each year by our distinguished jury. Current members of the jury are:
Dr. Amanda Barnard is an Office of the Chief Executive (OCE) Science Leader, and head of the Molecular & Materials Modeling lab at the Commonwealth Scientific and Industrial Research Organisation (CSIRO); joining as an Australian Research Council Queen Elizabeth II Fellow in 2009. She received her Ph.D. (Applied Physics) in from RMIT in 2003, followed by a Distinguished Postdoctoral Fellow in the Center for Nanoscale Materials at Argonne National Laboratory (USA), and the prestigious senior research position as Violette & Samuel Glasstone Fellow at the University of Oxford (UK) with an Extraordinary Research Fellowship at The Queen's College. Dr Barnard is a member of numerous Boards and national Committees, and regularly Chairs scientific conferences and symposia in Australia, Europe, USA and Asia. In 2016 she was promoted to Senior Associate Editor for Science Advances (AAAS) and continued her term on the Nature Index Panel (Nature Publishing Group). For her work she has won the 2009 Young Scientist Prize in Computational Physics from the International Union of Pure and Applied Physics, the 2009 Mercedes Benz Environmental Research Award, the 2009 Malcolm McIntosh Award from the Prime Minister of Australia for the Physical Scientist of the Year, the 2010 Frederick White Prize from the Australian Academy of Sciences, the 2010 Distinguished Lecturer Award from the IEEE South Australia, the 2010 Eureka Prize for Scientific Research, the 2014 ACS Nano Lectureship (Asia/Pacific) from the American Chemical Society, and the 2014 Feynman Prize in Nanotechnology (Theory) from the Foresight Institute, being the first woman to do so in the history of the award.
Margaret Brimble is the Director of Medicinal Chemistry and a Distinguished Professor at the University of Auckland where her research program focuses on the synthesis of bioactive natural products, antimicrobial peptides and peptidomimetics. She has published 390 papers, 50 reviews, holds 26 patents, won the 2012 RSNZ Rutherford Medal, the 2010 RSC Natural Products Award, the 2007 L’Oreal-UNESCO Women in Science laureate in Materials Science for Asia-Pacific and conferred the Queen’s Honour CNZM. She is President of IUPAC Organic and Biomolecular Division III, Chair of the Rutherford Foundation RSNZ, an Associate Editor for Organic and Biomolecular Chemistry and Past-President of the International Society of Heterocyclic Chemistry.
Professor Carroll's research focus is on the cell biology of the mammalian oocyte with a view to understanding its role in establishing a healthy pregnancy. His current work is directed toward understanding why eggs become less fertile as maternal age increases. John has spent most of his academic career at University College London (UCL) where he was Head of Department of Physiology before being appointed Associate Dean and Director of the UCL Division of Biosciences. Professor Carroll joined Monash University in September 2012 where he is Director of the Monash Biomedicine Discovery Institute and Dean of Biomedical and Psychological Sciences. John was inaugural Chair of the Faculty Gender Equity Committee and now Chairs the Athena SWAN gender equity team at Monash University.
Dr. Cathy Foley is the Deputy Director and Science Director of CSIRO Manufacturing. Previous to her current appointment, Cathy was Chief of the Division of Materials Science and Engineering. Her research is in superconducting devices and their application. Cathy has been involved in developing superconducting systems for mineral exploration, detection of metal for quality assurance in manufacturing, terahertz imaging, UXO detection and low noise wide bandwidth receivers. The most successful application has been LANDTEM™ which has assisted in unearthing over $6B in mineral worldwide.
Cathy was awarded a Public Service Medal on Australia Day in 2003. In the same year, Cathy won the Eureka Prize for the promotion of science. In 2009 Cathy was the NSW and National winner of the Telstra Women’s Business Award for Innovation. Cathy was also the recipient of the AUSIMM MIOTA award for LANDTEM™ as a mineral exploration tool. In 2013 she was awarded the NSW Premier's Award for Woman of the Year and in 2014 she was awarded the IEEE Council on Superconductivity Award for Continuing and Significant Contributions to the Field of Applied Superconductivity. Cathy and her team were awarded the prestigious Clunies Ross award for innovation and commercialisation for their invention, LANDTEM, in May of this year. Cathy has been an advocate for women in science, for the communication of science and science education over the last 30 years.
Jenny Graves is an evolutionary geneticist who works on Australian animals, including kangaroos and platypus, devils (Tasmanian) and dragons (lizards). Her group uses their distant relationship to humans to discover how genes and chromosomes and regulatory systems evolved, and how they work in all animals including humans. Her laboratory uses this unique perspective to explore the origin, function and fate of human sex genes and chromosomes, (in)famously predicting that the human Y chromosome will disappear. Jenny has received many honours and awards, including the Academy’s Macfarlane Burnet medal in 2006 and an AO in 2010. She is a Fellow of the Australian Academy of Science, and was on the Executive for 8 years, first as Foreign Secretary, then as Education Secretary with responsibility for the Academy's science education projects. She is 2006 L’Oreal-UNESCO Laureate for Women in Science.
Professor Hilton is the sixth Director of the Walter and Eliza Hall Institute, and head of the Department of Medical Biology in the Faculty of MDHS at the University of Melbourne. He is best known for his discoveries in four distinct areas of molecular haematology: leukaemia inhibitory factor, cytokine receptor family, suppressors of cytokine signalling, and identification of haematopoietic regulators through a large-scale forward mutagenesis screen. As Institute Director, he introduced mentoring programs for staff at WEHI, and formed a Gender Equity Committee to help alleviate problems faced by women scientists who are combining research with family responsibilities. His generosity and enthusiasm in mentoring was awarded the Eureka Prize for Outstanding Mentor of Young Researchers and a key reason he was invited to become a Victorian Male Champion of Change. Doug was also awarded an Officer of the Order of Australia, in the Queen’s Birthday Honours list for 2016.
Dianne is the former Chief Executive of the Royal Society of New Zealand, and has over 20 years experience in various management and governance roles in the tertiary education, science and health sectors. She is a Director of Powerhouse Ventures Ltd, the Cawthron Institute, and a member of the governance boards of the Dodd-Walls Centre for Photonic and Quantum Technologies, and the Ageing Well and Healthier Lives National Science Challenges. She is a Trustee of the Malaghan Institute of Medical Research and the Deafness Research Foundation (NZ), and is a member of the Advisory Board of the Centre for Brain Research. She was made an Officer of the New Zealand Order of Merit for services to education, a Companion of the Royal Society of New Zealand for services to science, and her qualifications include a BA, BSc, MSc (Hons) and PhD.
Prof Angela Moles leads the Big Ecology Lab in the School of Biological, Earth and Environmental Sciences at UNSW Australia. Angela’s research aims to understand the strategies plants have evolved to grow and reproduce in different environments. Her biggest project so far was the World Herbivory Project, in which she tested the hypothesis that plants in the tropics lose more of their leaves to animals than do plants in colder regions. To collect data for this project, Angela travelled for 2 years, establishing study sites in 75 different ecosystems including tundra in Greenland, Sweden and Alaska, savannas in Zambia, South Africa and Australia, rainforests in the Congo, Mexico, Panama, Peru and China, and deserts in Arizona, Israel, and Australia. Her findings have challenged many traditional theories about the factors that shape large scale patterns in ecology. Angela won the 2013 Frank Fenner Prize for Life Scientist of the Year, the 2011 Eureka prize for Outstanding Young Researcher, and a 2008 L’Oreal for Women in Science fellowship.
Laureate Professor Ingrid Scheffer is a physician-scientist whose work as a paediatric neurologist and epileptologist at the University of Melbourne has led the field of epilepsy genetics over more than 20 years, in collaboration with Professor Samuel Berkovic and molecular geneticists. This resulted in identification of the first epilepsy gene and many more genes subsequently. Professor Scheffer has described many novel epilepsy syndromes and refines genotype–phenotype correlation. Her major interests are in the genetics of the epilepsies, epilepsy syndromology and translational research. She also has research projects in the genetics of speech and language disorders, autism spectrum disorders and intellectual disability. She recently led the first major reclassification of the epilepsies in two decades as Chair of the International League Against Epilepsy Commission for Classification and Terminology. She has received many awards: 2007 American Epilepsy Society Clinical Research Recognition Award, 2009 RACP Eric Susman Prize, 2013 GSK Award for Research Excellence, ILAE Ambassador for Epilepsy Award, 2013 Australian Neuroscience Medallion, 2013 Emil Becker Prize for child neurology and the L’Oréal-UNESCO Women in Science Laureate for the Asia-Pacific region for 2012. In 2014, she was elected as a Fellow of the Australian Academy of Science and also elected as Vice-President and Foundation Fellow of the Australian Academy of Health and Medical Sciences. She was a co-recipient of the 2014 Prime Minister’s Prize for Science. She was awarded the Order of Australia in 2014.
Professor Eva Segelov was appointed as the Professor and Director of Oncology at Monash Health and Monash University in February 2017. She is an Honorary Associate of the NHMRC Clinical Trials Centre, Sydney Medical School and previously Associate Professor at the University of New South Wales and Senior Medical Oncologist at St Vincent’s Hospital, Sydney. She is a recognised national and international expert in the fields of gastrointestinal cancer, including neuroendocrine tumours, and breast cancer, with a 20 year history of management of patients in a multidisciplinary setting.
Professor Segelov is an active member of the Australian Gastrointestinal Trials Group (AGITG), as a Board Member and Convenor of the Annual Scientific Meeting. She is Chair of the Gastrointestinal Group of the Clinical Oncological Society of Australia (COSA). In 2016 she was nominated as a European Society of Medical Oncology (ESMO) faculty member for the CUP, Endocrine Tumours, and Others group. She is an Associate Editor of Journal of Global Oncology (ASCO); Editorial Board member of JoVE Cancer Research; ESMO 2019 Scientific Sub-Committee member for Neuroendocrine cancer; co-Track Chair of Gastrointestinal Cancer for the 2017 ESMO Asia Annual Scientific Meeting and co-founder of the Commonwealth Neuroendocrine Tumour Society (CommNETS), an international research collaborative
Professor Segelov has led multiple national and international oncology clinical trials, including investigator-initiated studies. Her research interests relate to translational studies of targeted therapies in defined subpopulations to increase benefit and reduce the toxicity of cancer treatments. She has published over 80 articles, expert reviews, and book chapters and is a frequent invited speaker at national and international conferences. Professor Segelov has a particular interest in professional development using innovative learning techniques and has developed the Seminal Advances Preceptorship in Cancer courses, now being run through Monash University. She was awarded the UNSW Vice Chancellors Award for Teaching Excellence in 2006.
The Jury considers the following when reviewing applications:
Taking into account academic records, ability to plan and conduct research, ability to interpret and communicate research findings, evidence of originality, initiative and productivity, and strong recommendation in reference letters.
Taking into account the relevance of the research and its impact, the originality of the research proposal, and whether it is presented in a clear and compelling way.